2-(Difluoromethoxy)-3-iodopyridine

Catalog No.: 
ACTXLJ792
CAS No.: 
2089318-91-0
Molecular Formula: 
C6H4F2INO
Molecular Weight: 
271.00
2-(Difluoromethoxy)-3-iodopyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$325.00InquiryInquiry
250mg97%$674.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Difluoromethoxy)-3-iodopyridine
IUPAC Name2-(difluoromethoxy)-3-iodopyridine
MDL No.MFCD30189407
Molecular FormulaC6H4F2INO
Molecular Weight271.00
SMILESIC1=CC=CN=C1OC(F)F
InChI KeyOAXGVDCNTLLSSS-UHFFFAOYSA-N
SynonymPyridine, 2-(difluoromethoxy)-3-iodo-;2-(Difluoromethoxy)-3-iodopyridine
CAS No.2089318-91-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTXLJ792 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJQMY892 route compound structure diagram
    ACJQMY892111079-46-0In Stock
  4. Then
  5. ACTXLJ792 route product structure diagram
    ACTXLJ7922089318-91-0
Inquiry

2. ACTXLJ792 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCYJB908 route compound structure diagram
    ACCYJB908113975-22-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTXLJ792 route product structure diagram
    ACTXLJ7922089318-91-0
Inquiry

3. ACTXLJ792 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCXIY987 route compound structure diagram
    ACCXIY987265981-13-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTXLJ792 route product structure diagram
    ACTXLJ7922089318-91-0
Inquiry

Comments (0)